» Authors » Nigel A Cunliffe

Nigel A Cunliffe

Explore the profile of Nigel A Cunliffe including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 121
Citations 2522
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Pitzer V, Ndeketa L, Asare E, Hungerford D, Lopman B, Jere K, et al.
NPJ Vaccines . 2024 Nov; 9(1):227. PMID: 39562592
Rotarix® vaccine was introduced into the Malawi national immunization program in October 2012. We analyzed data on children <5 years old hospitalized with acute gastroenteritis from January 2012 to June...
2.
Ashton P, Katuah Z, Botomani A, Kutambe B, Cunliffe N, von Mentzer A, et al.
Access Microbiol . 2024 Nov; 6(11). PMID: 39559263
We announce the deposition of the first two enterotoxigenic (ETEC) genomes from Malawi. They were isolated from the faeces of asymptomatically infected children obtained in 2014. Both genomes encode the...
3.
Morgan B, Lyons E, Handley A, Bogdanovic-Sakran N, Pavlic D, Witte D, et al.
Viruses . 2024 Sep; 16(9). PMID: 39339964
High titres of rotavirus-specific maternal antibodies may contribute to lower rotavirus vaccine efficacy in low- and middle-income countries (LMICs). RV3-BB vaccine (G3P[6]) is based on a neonatal rotavirus strain that...
4.
Chaguza C, Chibwe I, Chaima D, Musicha P, Ndeketa L, Kasambara W, et al.
Nat Commun . 2024 Jul; 15(1):6291. PMID: 39060226
Malawi experienced its deadliest Vibrio cholerae (Vc) outbreak following devastating cyclones, with >58,000 cases and >1700 deaths reported between March 2022 and May 2023. Here, we use population genomics to...
5.
Pitzer V, Ndeketa L, Asare E, Hungerford D, Jere K, Cunliffe N
medRxiv . 2024 Jun; PMID: 38853885
Background: Rotarix rotavirus vaccine was introduced into the Malawi national immunization program in October 2012. We used a previously developed mathematical models to estimate overall vaccine effectiveness over a 10-year...
6.
Atlas H, Conteh B, Islam M, Jere K, Omore R, Sanogo D, et al.
Open Forum Infect Dis . 2024 Mar; 11(Suppl 1):S6-S16. PMID: 38532963
Background: is a leading cause of acute watery diarrhea, dysentery, and diarrhea-attributed linear growth faltering, a precursor to stunting and lifelong morbidity. Several promising vaccines are in development and field...
7.
Morozoff C, Ahmed N, Chinkhumba J, Islam M, Jallow A, Ogwel B, et al.
Open Forum Infect Dis . 2024 Mar; 11(Suppl 1):S41-S47. PMID: 38532961
Background: Comparative costs of public health interventions provide valuable data for decision making. However, the availability of comprehensive and context-specific costs is often limited. The Enterics for Global Health (EFGH)...
8.
Liu J, Garcia Bardales P, Islam K, Jarju S, Juma J, Mhango C, et al.
Open Forum Infect Dis . 2024 Mar; 11(Suppl 1):S34-S40. PMID: 38532960
Background: Quantitative polymerase chain reaction (qPCR) targeting has been proven to be highly efficient in detecting in clinical samples compared to culture-based methods, which underestimate burden by 2- to 3-fold....
9.
Benedicto-Matambo P, Avolio L, Badji H, Batool R, Khanam F, Munga S, et al.
Open Forum Infect Dis . 2024 Mar; 11(Suppl 1):S58-S64. PMID: 38532958
Background: Molecular diagnostics on human fecal samples have identified a larger burden of shigellosis than previously appreciated by culture. Evidence of fold changes in immunoglobulin G (IgG) to conserved and...
10.
Babb C, Badji H, Bhuiyan M, Cornick J, Qureshi S, Sonye C, et al.
Open Forum Infect Dis . 2024 Mar; 11(Suppl 1):S65-S75. PMID: 38532957
Background: The measurement of fecal inflammatory biomarkers among individuals presenting to care with diarrhea could improve the identification of bacterial diarrheal episodes that would benefit from antibiotic therapy. We reviewed...